Labeler
AbbVie Inc. NDC Codes
AbbVie Inc. lists 101 finished drug products in the FDA NDC Directory under NDC labeler codes 0032, 0074.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Synthroid, Skyrizi, Creon, Humira, Lupron Depot-PED, Lupron Depot, Juvmo, Rinvoq, Zemplar, Venclexta, Qulipta, Kaletra, Emrelis, Depakote, Norvir
- Active ingredients
- Levothyroxine sodium, Pancrelipase amylase, Pancrelipase lipase, Pancrelipase protease, Risankizumab, Divalproex sodium, Ritonavir, Tavapadon, Upadacitinib, Paricalcitol, Atogepant, Lopinavir
- NDC labeler codes
- 0032, 0074
- Strengths (from the 100 most recently listed products)
- Risankizumab 180 mg/1.2mL; Pancrelipase amylase 30000 [USP'U]/1; Pancrelipase lipase 6000 [USP'U]/1; Pancrelipase protease 19000 [USP'U]/1; Pancrelipase lipase 36000 [USP'U]/1; Pancrelipase amylase 180000 [USP'U]/1; Pancrelipase protease 114000 [USP'U]/1; Pancrelipase amylase 60000 [USP'U]/1; Pancrelipase lipase 12000 [USP'U]/1; Pancrelipase protease 38000 [USP'U]/1; Pancrelipase amylase 15000 [USP'U]/1; Pancrelipase lipase 3000 [USP'U]/1; Pancrelipase protease 9500 [USP'U]/1; Pancrelipase lipase 24000 [USP'U]/1; Pancrelipase protease 76000 [USP'U]/1; Pancrelipase amylase 120000 [USP'U]/1; Divalproex sodium 250 mg/1; Ritonavir 100 mg/1; Risankizumab 150 mg/mL; Divalproex sodium 500 mg/1
- Dosage forms
- Kit, Tablet, Tablet, Film coated, Capsule, Delayed release pellets, Injection, Tablet, Extended release, Injection, Solution, Injection, Powder, Lyophilized, For solution, Capsule, Solution, Capsule, Delayed release, Tablet, Delayed release, Capsule, Liquid filled, Suspension, Liquid, Powder, For solution, Pellet, Powder
- Routes
- Oral, Intravenous, Subcutaneous, Respiratory (Inhalation), Enteral, Endotracheal
- Drug classes (FDA established)
- l-Thyroxine, Protease Inhibitor, Interleukin-23 Antagonist, Anti-epileptic Agent, Mood Stabilizer, Cytochrome P450 3A Inhibitor, Janus Kinase Inhibitor, Vitamin D Analog, Vitamin D2 Analog, Calcitonin Gene-related Peptide Receptor Antagonist, BCL-2 Inhibitor, Hepatitis C Virus NS3/4A Protease Inhibitor, Hepatitis C Virus NS5A Inhibitor, Gonadotropin Releasing Hormone Receptor Antagonist, Calcineurin Inhibitor Immunosuppressant, General Anesthetic, Monobactam Antibacterial, beta Lactamase Inhibitor, Aromatic Amino Acid
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 182 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Depakotedivalproex sodium | Divalproex sodium 125 mg/1 | Tablet, Delayed releaseOral | 0074-7325 | 00074-7325-13 | — |
AbbVie Inc.: common questions
- What is AbbVie Inc.'s NDC labeler code?
- 0032, 0074. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for AbbVie Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.